Dark

Check out our Dark Pool Levels

SNCE
Science 37 Holdings, Inc. Common Stock
stock NASDAQ

Inactive

Mar 11, 2024

5.75USD+0.349%(+0.02)49,100

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-5.73)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 18, 2022

08:01AM EST Worldwide Clinical Trials And Science 37 Partner To 'Advance Agile Clinical Trials and Accelerate Study Timelines' Benzinga

07:55AM EST Worldwide Clinical Trials and Science 37 Partner to GlobeNewswire Inc

Dec 7, 2021

07:57AM EST Science 37 Says Has 'added capability to meet regulatory requirements and deploy its full-stack, end-to-end technology platform into China and Russia' Benzinga

07:55AM EST Science 37, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System, today announced it has added capability to meet regulatory requirements and deploy its full-stack, end-to-end technology platform into China and Russiafurther extending penetration into the Asia-Pacific market and providing sponsors the ability to more effectively run global decentralized clinical trials. GlobeNewswire Inc

Nov 17, 2021

07:55AM EST Science 37 Reveals a Pivotal Shift in the Clinical GlobeNewswire Inc

Nov 15, 2021

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:56AM EST Science 37 Holdings Sees FY21 Sales $53.7M-$54.2M Vs. $52.07M Est. Benzinga

10:56AM EST Science 37 Holdings Q3 Sales $14.20M Beat $13.09M Estimate Benzinga

07:00AM EST Science 37 Holdings, Inc. (Nasdaq: SNCE), (Science 37) the Operating System for todays more agile clinical trials, today reported its financial results for the quarter ended September 30, 2021. GlobeNewswire Inc

Nov 1, 2021

11:49AM EDT Lake Street Initiates Coverage On Science 37 Hldgs with Buy Rating, Announces Price Target of $15 Benzinga

08:00AM EDT Science 37 Holdings, Inc. (Nasdaq: SNCE), the Operating System for todays more agile clinical trials, today announced it will report third quarter 2021 financial results before the market opens on Monday, November 15, 2021. Company management will host a corresponding conference call at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time. GlobeNewswire Inc

05:43AM EDT William Blair Initiates Coverage On Science 37 Hldgs with Outperform Rating Benzinga

05:17AM EDT Baird Initiates Coverage On Science 37 Hldgs with Outperform Rating, Announces Price Target of $15 Benzinga

Oct 27, 2021

08:00AM EDT Science 37 and CMIC Announce Partnership to Advance GlobeNewswire Inc

08:00AM EDT Science 37, 3H Medi Solution Collaborate To Enable Decentralized Clinical Trials In Japan And Accelerate Patient Enrollment Benzinga

07:55AM EDT Science 37 and 3H Medi Solution Collaborate to Enable GlobeNewswire Inc

Oct 26, 2021

11:46AM EDT EXCLUSIVE: Science37 CEO, David Coman Says Co Will Increase Its Net Bookings From $112M To $444M By 2025 Benzinga

11:44AM EDT EXCLUSIVE: Science37 CEO, David Coman Says Co Will Increase Its Growth Margin To 55% By 2025 Benzinga

11:43AM EDT EXCLUSIVE: Science37 CEO, David Coman Says Co Is Going To Be Growing Geographically, Commercially, And Technologically In The Next Several Growth, Says Co Is Disrupting A $60B Market Benzinga

11:39AM EDT EXCLUSIVE: Science37 CEO, David Coman Says Co's Has Big Customer Base Including Amgen, Sanofi, Genentech, And Johnson & Johnson Benzinga

11:20AM EDT EXCLUSIVE: LifeSci Acquisition II Corp Merger Partner, Science37 CEO, David Coman Now Interviewing On Benzinga's 'SPACs Attack' Show Benzinga

08:57AM EDT EXCLUSIVE: LifeSci Acquisition II Corp Merger Partner, Science37 CEO, David Coman To Appear On Benzinga's 'SPACs Attack' Show At 11:15 a.m. ET Benzinga

Oct 22, 2021

10:18AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 22, 2021 Benzinga

07:37AM EDT Cowen & Co. Initiates Coverage On Science 37 Hldgs with Outperform Rating, Announces Price Target of $14 Benzinga

Oct 13, 2021

07:55AM EDT Science 37, the Operating System for todays more agile clinical trials, announced Elisa Cascade has joined Science 37 and its senior executive team as Chief Product Officer. Science 37 veteran Chris Ceppi has been appointed to serve as Chief Technology Officer. GlobeNewswire Inc

Oct 12, 2021

07:55AM EDT With this important addition to its Board of Directors, Science 37 further advances its mission to accelerate clinical trials by enabling universal access to patients and providers. GlobeNewswire Inc

Share